Radiotherapy & Oncology
Volume 96, Issue 1 , Pages 13-18 , July 2010

Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial

  • Abrahim Al-Mamgani

      Affiliations

    • Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands.
  • ,
  • Wilma D. Heemsbergen

      Affiliations

    • The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • ,
  • Peter C. Levendag

      Affiliations

    • Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
  • ,
  • Joos V. Lebesque

      Affiliations

    • The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Received 24 February 2009 ,Revised 19 February 2010 ,Accepted 23 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0167-8140(10)00127-1

doi: 10.1016/j.radonc.2010.02.022

Radiotherapy & Oncology
Volume 96, Issue 1 , Pages 13-18 , July 2010